Gastric inhibitory polypeptide and splanchnic blood perfusion: Augmentation of the islet blood flow increase in hyperglycemic rats

Peptides

Volumn 18, Issue 7, 1997, Pages 1055-1059

  Annika, Svensson M ^a   Suad, Efendic ^b   CLaes Göran, Östenson ^b   Jansson, Leif ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Blood flow; Gastric inhibitory polypeptide; Incretin; Insulin release; Pancreas; Pancreatic islets; Splanchnic

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GLUCOSE; INCRETIN; INSULIN; MICROSPHERE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUODENUM; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTESTINE BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT; SPLANCHNIC BLOOD FLOW;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC INHIBITORY POLYPEPTIDE; HYPERGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; MALE; MICROSPHERES; RATS; RATS, SPRAGUE-DAWLEY; SPLANCHNIC CIRCULATION;

ANIMALIA;

EID: 0030716316     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00031-4     Document Type: Article

References (34)

1. Ahrén B., Håkansson R., Lundquist I., Sjölund K., Sundler F. GIP-like immunoreactivity in glucagon cells. Interactions between GIP and glucagon on insulin release. Acta Physiol. Scand. 112:1981;233-242.
2. Ahrén B., Pettersson M., Uvnäs-Moberg K., Gutniak M., Efendic S. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. Diabetes Res. Clin. Pract. 13:1991;153-161.
3. Atef N., Ktorza A., Picon L., Pénicaud L. Increased islet blood flow in obese rats Role of the autonomic nervous system. Am. J. Physiol. 262:1992;E736-E740.
4. Atef N., Ktorza A., Pénicaud L. CNS involvement in the glucose induced increase of islet blood flow in obese Zucker rats. Int. J. Obes. 19:1995;103-107.
5. Brunicardi F. C., Druck P., Seymour N. E., Sun Y. S., Elahi D., Andersen D. K. Selective neurohormonal interactions in islet cell secretion in the isolated perfused human pancreas. J. Surg. Res. 48:1990;273-278.
6. Chan C. B., Pederson R. A., Buchan A. M., Tubesing K. B., Brown J. C. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat. Diabetes. 33:1984;536-542.
7. Chan C. B., Pederson R. A., Buchan A. M., Tubesing K. B., Brown J. C. Gastric inhibitory polypeptide and hyperinsulinemia in the Zucker (fa/fa) rat A developmental study. Int. J. Obes. 9:1985;137-146.
8. Creutzfeldt W. The incretin concept today. Diabetologia. 16:1979;75-85.
9. Creutzfeldt W., Ebert R. New developments in the incretin concept. Diabetologia. 28:1985;565-573.
10. Fehmann H. C., Göke B., Göke R., Trautmann M. E., Arnold R. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas. FEBS Lett. 252:1989;109-112.
11. Gutniak M., Ørskov C., Holst J. J., Ahrén B., Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 326:1992;1316-1322.
12. Higashimoto Y., Simchock J., Liddle R. A. Molecular cloning of rat glucose-dependent insulinotropic peptide (GIP). Biochim. Biophys. Acta. 1132:1992;72-74.
13. Holst J. J., Oørskov C., Nielsen O. V., Schwartz T. W. Truncated glucagon-like peptide-1, an insulin-releasing hormone from the distal gut. FEBS Lett. 211:1987;169-174.
14. Huffman L. J., Connors J. M., Hedge G. A. VIP and its homologues increase vascular conductance in certain endocrine and exocrine glands. Am. J. Physiol. 254:1988;E435-E442.
15. Jansson L. Glucose stimulation of pancreatic islet blood flow by redistribution of the blood flow within the whole pancreatic gland. Pancreas. 3:1988;409-412.
16. Jansson L. The regulation of pancreatic islet blood flow. Diabetes Metab. Rev. 4:1994;407-416.
17. Jansson L., Hellerström C. A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using non-radioactive microspheres. Acta Physiol. Scand. 113:1981;371-374.
18. Jansson L., Hellerström C. Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia. 25:1983;45-50.
19. Jansson L., Hellerström C. Glucose-induced changes in pancreatic islet blood flow mediated by central nervous system. Am. J. Physiol. 251:1986;E644-E647.
20. Kaplan A. M., Vigna S. R. Gastric inhibitory polypeptide (GIP) binding sites in rat brain. Peptides. 15:1994;297-302.
21. Kogire M., Inoue K., Doi R., Takaori K., Yun M., Fujii N., Yajima H., Tobe T. Effects of synthetic human gastric inhibitory polypeptide on splanchnic circulation in dogs. Gastroenterology. 95:1988;1636-1640.
22. Kogire M., Inoue K., Sumi S., Doi R., Yun M., Kaji H., Tobe T. Effects of gastric inhibitory polypeptide and glucagon on portal venous and hepatic arterial flow in conscious dogs. Dig. Dis. Sci. 37:1992;1666-1670.
23. Krarup T., Groop P. H. Physiology and pathophysiology of GIP A review. Scand. J. Clin. Lab. Invest. 51:1991;571-579.
24. Muller M. K., Scheck T., Demol P., Goebell H. Interaction of acetylcholine and gastric inhibitory polypeptide on endocrine and exocrine rat pancreatic secretion Augmentation of acetylcholine-induced amylase and volume secretion by the insulinotropic action of gastric inhibitory polypeptide. Digestion. 33:1986;45-52.
25. Oørskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia. 35:1992;701-711.
26. Pederson R. A., Campos R. V., Buchan A. M., Chisholm C. B., Russell J. C., Brown J. C. Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and the JCR:LA-corpulent. Int. J. Obes. 15:1991;461-470.
27. Plaisancie P., Bernard C., Chayvialle J. A., Cuber J. C. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon. Endocrinology. 135:1994;2398-2403.
28. Roberge J. N., Brubaker P. L. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology. 133:1993;233-240.
29. Sandberg E., Ahrén B., Tendler D., Efendic S. Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide-induced insulin secretion in the perfused rat pancreas. Acta Endocrinol. 117:1988;545-551.
30. Suzuki S., Kawai K., Ohashi S., Watanabe Y., Yamashita K. Interaction of glucagon-like peptide-1 (7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas. Metabolism. 41:1992;359-363.
31. Svensson, A. M.; Östenson, C.-G; Efendic, S.; Jansson, L. Effect of GLP-1 (7-36) amide on pancreatic and intestinal blood flow in the spontaneously diabetic GK rat. Diabetologia 37(Suppl. 1):A72; 1994 [Abstract.].
32. Usdin T. B., Mezey E., Button D. C., Brownstein M. J., Bonner T. I. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology. 133:1993;2861-2870.
33. Wahl M. A., Plehn R. J., Landsbeck E. A., Verspohl E. J., Ammon H. P. Are ionic fluxes of pancreatic beta cells a target for gastric inhibitory polypeptide? Mol. Cell. Endocrinol. 90:1992;117-123.
34. Yasuda K., Inagaki N., Yamada Y., Kubota A., Seino S., Seino Y. Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells Its structure and functional properties. Biochem. Biophys. Res. Commun. 205:1994;1556-1562.